diversity Archives -

Almost half (48%) of cancer clinical trials in the US have no Hispanic or Latin American subjects, and

Study exposes lack of diversity in US cancer trials

https://pharmaphorum.com/news/study-exposes-lack-of-diversity-in-us-cancer-trials/

News/ News/ News/ Patients/ R&D

Pharmacy chain Walgreens plans to disrupt clinical trial sector

Phil Taylor clinical trials, CVS, decentralised clinical trials, diversity, patients, Walgreens 0 Comment

Walgreens is the latest US retail pharmacy giant to have a go at disrupting the clinical trials industry,

Pharmacy chain Walgreens plans to disrupt clinical trial sector

https://pharmaphorum.com/news/pharmacy-chain-walgreens-plans-to-disrupt-clinical-trial-sector/

Oncology/ Sales and Marketing/ Views & Analysis/ Views & Analysis/ Views and analysis/ White Papers/ Whitepapers

The value of diverse patient representation and engagement in cancer treatment

mike.hammerton@pharmaphorum.com cancer patients, cancer treatment, COVID-19, diversity, Envision Pharma Group, patient centricity 0 Comment

To improve outcomes for cancer patients and take advantage of the ground-breaking scientific and technological progress made in

The value of diverse patient representation and engagement in cancer treatment

https://pharmaphorum.com/whitepapers/value-of-diverse-patient-representation-and-engagement-cancer/

R&D/ Views & Analysis/ Views and analysis

Can technology help diversify clinical trials?

mike.hammerton@pharmaphorum.com clinical trials, decentralised clinical trials, diversity, diversity and inclusion, KPMG 0 Comment

This is the second in a two-part series examining how pharma can embrace the DEI agenda to create

Can technology help diversify clinical trials?

https://pharmaphorum.com/r-d/can-technology-help-diversify-clinical-trials/

R&D/ Views & Analysis/ Views and analysis

Why are clinical trials struggling with diversity?

mike.hammerton@pharmaphorum.com clinical trial diversity, clinical trials, COVID-19, diversity, diversity and inclusion, randomised control trials 0 Comment

In the diverse world we live in, the products we produce, the services we create and the places

Why are clinical trials struggling with diversity?

https://pharmaphorum.com/r-d/why-are-clinical-trials-struggling-with-diversity/

Sales and Marketing/ Views & Analysis/ Views and analysis

When diversity, equity and inclusion are more than just buzzwords

mike.hammerton@pharmaphorum.com diversity, diversity and inclusion, equity, Horizon Therapeutics, inclusion, Petra Molan 0 Comment

Throughout my 30-year career, there have been many times it was obvious I stood out just because of

When diversity, equity and inclusion are more than just buzzwords

https://pharmaphorum.com/sales-marketing/when-diversity-equity-and-inclusion-are-more-than-just-buzzwords/

Digital/ News/ News/ News/ News/ Patients/ R&D

Financing pushes value of clinical trial tech firm Reify to $4.8bn

Phil Taylor clinical trials, decentralised clinical trials, digital health, diversity, patients, recruitment, Reify Health 0 Comment

Reify Health has completed fourth-round financing that adds $220 million to its cash reserves and pushes its valuation

Financing pushes value of clinical trial tech firm Reify to $4.8bn

https://pharmaphorum.com/news/financing-pushes-value-of-clinical-trial-tech-firm-reify-to-4-8bn/

Digital/ News/ News

CVS, Medable alliance aims to tackle diversity in clinical trials

Phil Taylor clinical trials, CVS Health, decentralised trials, digital, digital health, diversity, Medable, patient recruitment 0 Comment

CVS Health has said it will beef up its clinical trials operations, improving its ability to recruit patients

CVS, Medable alliance aims to tackle diversity in clinical trials

https://pharmaphorum.com/news/cvs-medable-alliance-aims-to-tackle-diversity-in-clinical-trials/

Patients/ R&D/ Views & Analysis/ Views & Analysis/ Views and analysis

Importance of diversity in pharma and clinical trials

mike.hammerton@pharmaphorum.com clinical trials, decentralised clinical trials, diversity, impetus, Natalie Yeadon, virtual clinical trials 0 Comment

“Diversity.” It’s a word that is very commonly thrown around right now, not just in pharma and healthcare

Importance of diversity in pharma and clinical trials

https://pharmaphorum.com/r-d/importance-diversity-pharma-and-clinical-trials-impetus/

Trending

diversity

Login